Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

🚨IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION Based on Dr. William Makis MD's commonly shared dosing framework Thousands of people reference this ivermectin dosing chart. Below is a simplified breakdown organized by body weight (mg/kg per day). 📌LOW DOSE ≤ 0.5 mg/kg/day Best For: • Cancers in remission...

genixmeds's profile picture

GENIX MEDS

18,143 subscribers

31,014 Aufrufe • vor 1 Monat •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

0 Kommentare

Keine Kommentare verfügbar

Kommentare vom Original-Post werden hier angezeigt

Ähnliche Videos

🚨 DR. WILLIAM MAKIS’ IVERMECTIN DOSING GUIDE FOR CANCER & PREVENTION IS SPREADING FAST ONLINE Thousands are now discussing Dr. William Makis MD’s categorized Ivermectin dosing approach based on body weight (mg/kg/day) and cancer severity. Here’s the breakdown people keep sharing: LOW DOSE: ≤ 0.5 mg/kg/day Often discussed for: • Remission support • Prevention strategies • Strong family cancer history ⚠️ Reports shared online describe minimal long term side effects at lower ranges. Access them via PharmacyinUSA MEDIUM DOSE: 1.0 mg/kg/day Most commonly discussed for: • Breast cancer • Lung cancer • Colon cancer • Pancreatic cancer • Renal cancers ⚠️ Supporters claim this is the “standard starting range” used in many repurposed drug discussions. HIGH DOSE: 2.0 mg/kg/day Typically discussed for: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers ⚠️ Some anecdotal reports mention temporary visual side effects at higher dosing ranges. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Usually discussed only for: • Advanced metastatic disease • Late stage aggressive cancers ⚠️ High dose use remains highly controversial and experimental. Quick weight example for a 60 kg (132 lb) adult: • Low: 30 mg/day • Medium: 60 mg/day • High: 120 mg/day • Very High: 150+ mg/day Why this conversation keeps exploding online: ✅ Ivermectin has decades of human use worldwide ✅ Growing interest in repurposed cancer drugs ✅ Observational and preclinical research continues expanding ✅ Patients are increasingly sharing personal experiences publicly. (Jase Medical) Still, millions are now asking why inexpensive repurposed drugs are generating so much public interest while receiving so little mainstream discussion. **The chart has been upscaled for better visibility** #Ivermectin #Fenbendazole #Mebendazole
5:52

🚨 DR. WILLIAM MAKIS’ IVERMECTIN DOSING GUIDE FOR CANCER & PREVENTION IS SPREADING FAST ONLINE Thousands are now discussing Dr. William Makis MD’s categorized Ivermectin dosing approach based on body weight (mg/kg/day) and cancer severity. Here’s the breakdown people keep sharing: LOW DOSE: ≤ 0.5 mg/kg/day Often discussed for: • Remission support • Prevention strategies • Strong family cancer history ⚠️ Reports shared online describe minimal long term side effects at lower ranges. Access them via PharmacyinUSA MEDIUM DOSE: 1.0 mg/kg/day Most commonly discussed for: • Breast cancer • Lung cancer • Colon cancer • Pancreatic cancer • Renal cancers ⚠️ Supporters claim this is the “standard starting range” used in many repurposed drug discussions. HIGH DOSE: 2.0 mg/kg/day Typically discussed for: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers ⚠️ Some anecdotal reports mention temporary visual side effects at higher dosing ranges. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Usually discussed only for: • Advanced metastatic disease • Late stage aggressive cancers ⚠️ High dose use remains highly controversial and experimental. Quick weight example for a 60 kg (132 lb) adult: • Low: 30 mg/day • Medium: 60 mg/day • High: 120 mg/day • Very High: 150+ mg/day Why this conversation keeps exploding online: ✅ Ivermectin has decades of human use worldwide ✅ Growing interest in repurposed cancer drugs ✅ Observational and preclinical research continues expanding ✅ Patients are increasingly sharing personal experiences publicly. (Jase Medical) Still, millions are now asking why inexpensive repurposed drugs are generating so much public interest while receiving so little mainstream discussion. **The chart has been upscaled for better visibility** #Ivermectin #Fenbendazole #Mebendazole

PharmacyinUSA

90,446 Aufrufe • vor 1 Monat

22 Year Old With Stage 4 Turbo Cancer Post Covid "Vax" Has Major Improvement From Ivermectin and Fenbendazole‼️ Dr. William Makis, a Canadian Oncologist, shares another success story of Ivermectin overcoming stage 4 turbo cancer in a 22 year old by taking 18 mg Ivermectin tablets daily for 19 days‼️ "Another IVERMECTIN + FENBENDAZOLE success story in Alberta where AHS Cancer Care has FAILED‼️ Turbo Cancer (Stage 4 Renal Carcinoma). "There is tremendous amount of Evidence that high dose Ivermectin is extremely effective in Treating many types of Cancers"‼️🙏👇 Credit 👉Dr. Makis💫👇👇 Full Podcast🔗👇👇
0:46

22 Year Old With Stage 4 Turbo Cancer Post Covid "Vax" Has Major Improvement From Ivermectin and Fenbendazole‼️ Dr. William Makis, a Canadian Oncologist, shares another success story of Ivermectin overcoming stage 4 turbo cancer in a 22 year old by taking 18 mg Ivermectin tablets daily for 19 days‼️ "Another IVERMECTIN + FENBENDAZOLE success story in Alberta where AHS Cancer Care has FAILED‼️ Turbo Cancer (Stage 4 Renal Carcinoma). "There is tremendous amount of Evidence that high dose Ivermectin is extremely effective in Treating many types of Cancers"‼️🙏👇 Credit 👉Dr. Makis💫👇👇 Full Podcast🔗👇👇

Sophia Dahl

130,241 Aufrufe • vor 1 Jahr

World Ivermectin Day 2024: "You can use high dose Ivermectin for the majority of Cancers...this is a dose that is 5 to 10 times the dose that people were using for COVID-19". There is no money in treating aggressive cancers with High Dose Ivermectin, Fenbendazole, Mebendazole For example, Fenbendazole and Mebendazole upregulate p53 tumor suppressor levels, that are low in people who took COVID-19 Vaccines and developed Turbo Cancer
4:00

World Ivermectin Day 2024: "You can use high dose Ivermectin for the majority of Cancers...this is a dose that is 5 to 10 times the dose that people were using for COVID-19". There is no money in treating aggressive cancers with High Dose Ivermectin, Fenbendazole, Mebendazole For example, Fenbendazole and Mebendazole upregulate p53 tumor suppressor levels, that are low in people who took COVID-19 Vaccines and developed Turbo Cancer

IvermectinKart | Ivermectin & Cancer cure store

1,876,317 Aufrufe • vor 8 Monaten

🚨NEARLY HALF OF CANCER PATIENTS TAKING IVERMECTIN + MEBENDAZOLE REPORTED CANCER DISAPPEARANCE OR TUMOR REGRESSION AFTER 6 MONTHS 84.4% EXPERIENCED CLINICAL BENEFIT 32.8% REPORTED NO EVIDENCE OF DISEASE 15.6% REPORTED TUMOR REGRESSION 36.1% REPORTED STABLE DISEASE Our study represents the largest and most compelling clinical signal to date supporting antiparasitic therapy in cancer.
1:34

🚨NEARLY HALF OF CANCER PATIENTS TAKING IVERMECTIN + MEBENDAZOLE REPORTED CANCER DISAPPEARANCE OR TUMOR REGRESSION AFTER 6 MONTHS 84.4% EXPERIENCED CLINICAL BENEFIT 32.8% REPORTED NO EVIDENCE OF DISEASE 15.6% REPORTED TUMOR REGRESSION 36.1% REPORTED STABLE DISEASE Our study represents the largest and most compelling clinical signal to date supporting antiparasitic therapy in cancer.

Joe Tippens

56,040 Aufrufe • vor 3 Monaten

🚨NEARLY HALF OF CANCER PATIENTS TAKING IVERMECTIN + MEBENDAZOLE REPORTED CANCER DISAPPEARANCE OR TUMOR REGRESSION AFTER 6 MONTHS 84.4% EXPERIENCED CLINICAL BENEFIT 32.8% REPORTED NO EVIDENCE OF DISEASE 15.6% REPORTED TUMOR REGRESSION 36.1% REPORTED STABLE DISEASE Our study represents the largest and most compelling clinical signal to date supporting antiparasitic therapy in cancer. McCullough Foundation The Wellness Company Peter A. McCullough, MD, MPH® Harvey Risch Kelly Victory MD James Thorp MD Dr. Drew Peter Gillooly Foster Coulson
1:34

🚨NEARLY HALF OF CANCER PATIENTS TAKING IVERMECTIN + MEBENDAZOLE REPORTED CANCER DISAPPEARANCE OR TUMOR REGRESSION AFTER 6 MONTHS 84.4% EXPERIENCED CLINICAL BENEFIT 32.8% REPORTED NO EVIDENCE OF DISEASE 15.6% REPORTED TUMOR REGRESSION 36.1% REPORTED STABLE DISEASE Our study represents the largest and most compelling clinical signal to date supporting antiparasitic therapy in cancer. McCullough Foundation The Wellness Company Peter A. McCullough, MD, MPH® Harvey Risch Kelly Victory MD James Thorp MD Dr. Drew Peter Gillooly Foster Coulson

Nicolas Hulscher, MPH

761,949 Aufrufe • vor 3 Monaten

🚨 DR. WILLIAM MAKIS REVEALED THE IVERMECTIN DOSING STRATEGY HE'S USING IN CANCER PATIENTS. HERE'S WHAT HE'S SEEING. In a recent discussion, Dr. William Makis was asked a question many cancer patients are now researching: 📌 How does he use Ivermectin in cancer protocols? His answer surprised a lot of people. For most intermediate to high-grade cancers, Dr. Makis said his typical starting dose is: 💊 1 mg/kg per day For a 60 kg (132 lb) person, that's approximately: 📊 60mg daily According to him, that's roughly 5 times higher than the dose commonly used for parasitic infections. For lower-grade cancers, he often starts lower: 💊 0.5 mg/kg per day Examples discussed included: • Chronic Lymphocytic Leukemia (CLL) • Multiple Myeloma For a 60 kg person, that would be about: 📊 30mg daily And unlike many protocols circulating online, he noted that the dosing is typically: 📅 7 days per week But the dosage wasn't the part that got my attention. The timeline was. According to Dr. Makis, some patients may begin seeing changes in cancer markers within: ⏳ 3 to 4 weeks He specifically mentioned markers such as: 📉 PSA 📉 CEA 📉 CA-125 📉 Other cancer-related markers He explained that these markers can sometimes provide an early indication that something is changing before tumors physically shrink. Then come the scans. According to his experience: 📊 PET scans may begin showing reduced cancer activity within about a month. 📊 Physical tumor shrinkage often becomes visible after roughly 2 to 3 months on PET-CT, CT, or MRI imaging. That's why he generally recommends giving a protocol: ⏳ A full 3 months Before evaluating whether a meaningful response is occurring. But perhaps the most surprising statement came near the end. Dr. Makis said the best results he has personally seen were not necessarily from Ivermectin alone. According to him, some of the most dramatic responses occurred when patients combined: 💊 Ivermectin PLUS 💊 Chemotherapy That observation is likely to spark debate from every side of the conversation. Whether you agree with his conclusions or not, one thing is clear: More patients are reading studies. More doctors are discussing repurposed medicines. And more people are asking questions that weren't being asked a few years ago. That's why conversations around Ivermectin continue to grow across cancer communities worldwide. 🌐 Looking for Ivermectin, Fenbendazole, or Mebendazole? Explore RXMEDS.STORE. #Ivermectin #WilliamMakis #CancerResearch #CancerProtocol #RepurposedDrugs
3:34

🚨 DR. WILLIAM MAKIS REVEALED THE IVERMECTIN DOSING STRATEGY HE'S USING IN CANCER PATIENTS. HERE'S WHAT HE'S SEEING. In a recent discussion, Dr. William Makis was asked a question many cancer patients are now researching: 📌 How does he use Ivermectin in cancer protocols? His answer surprised a lot of people. For most intermediate to high-grade cancers, Dr. Makis said his typical starting dose is: 💊 1 mg/kg per day For a 60 kg (132 lb) person, that's approximately: 📊 60mg daily According to him, that's roughly 5 times higher than the dose commonly used for parasitic infections. For lower-grade cancers, he often starts lower: 💊 0.5 mg/kg per day Examples discussed included: • Chronic Lymphocytic Leukemia (CLL) • Multiple Myeloma For a 60 kg person, that would be about: 📊 30mg daily And unlike many protocols circulating online, he noted that the dosing is typically: 📅 7 days per week But the dosage wasn't the part that got my attention. The timeline was. According to Dr. Makis, some patients may begin seeing changes in cancer markers within: ⏳ 3 to 4 weeks He specifically mentioned markers such as: 📉 PSA 📉 CEA 📉 CA-125 📉 Other cancer-related markers He explained that these markers can sometimes provide an early indication that something is changing before tumors physically shrink. Then come the scans. According to his experience: 📊 PET scans may begin showing reduced cancer activity within about a month. 📊 Physical tumor shrinkage often becomes visible after roughly 2 to 3 months on PET-CT, CT, or MRI imaging. That's why he generally recommends giving a protocol: ⏳ A full 3 months Before evaluating whether a meaningful response is occurring. But perhaps the most surprising statement came near the end. Dr. Makis said the best results he has personally seen were not necessarily from Ivermectin alone. According to him, some of the most dramatic responses occurred when patients combined: 💊 Ivermectin PLUS 💊 Chemotherapy That observation is likely to spark debate from every side of the conversation. Whether you agree with his conclusions or not, one thing is clear: More patients are reading studies. More doctors are discussing repurposed medicines. And more people are asking questions that weren't being asked a few years ago. That's why conversations around Ivermectin continue to grow across cancer communities worldwide. 🌐 Looking for Ivermectin, Fenbendazole, or Mebendazole? Explore RXMEDS.STORE. #Ivermectin #WilliamMakis #CancerResearch #CancerProtocol #RepurposedDrugs

RXMEDS.STORE

36,776 Aufrufe • vor 26 Tagen

The LARGEST systematic review study ever conducted on ivermectin use in cancer patients identified 14 distinct anticancer mechanisms across 12 cancer types and found no safety concerns. Meanwhile, a recent study reported COMPLETE REMISSION of Stage IV cancers with fenbendazole.
1:15

The LARGEST systematic review study ever conducted on ivermectin use in cancer patients identified 14 distinct anticancer mechanisms across 12 cancer types and found no safety concerns. Meanwhile, a recent study reported COMPLETE REMISSION of Stage IV cancers with fenbendazole.

Nicolas Hulscher, MPH

90,113 Aufrufe • vor 5 Monaten

🚨 SHOCKING BOMBSHELL: They’ve been hiding this from you. Dr. Peter McCullough just exposed it in this video: A new real-world study of 197 cancer patients treated with low-dose Ivermectin (25 mg) + Mebendazole (250 mg). After just 6 months: 84.4% had clinical benefit 48.4% had tumor reduction or no detectable disease 86.9% completed treatment with only mild side effects Patients got scans every 3 months. Dr. McCullough breaks it down: tiny doses, massive results, and almost no downside. This is what the cancer industry and Big Pharma fear most — cheap, repurposed drugs actually working while they push trillion-dollar chemo and endless “treatments.” Cancer isn’t being cured because it’s too profitable.
1:33

🚨 SHOCKING BOMBSHELL: They’ve been hiding this from you. Dr. Peter McCullough just exposed it in this video: A new real-world study of 197 cancer patients treated with low-dose Ivermectin (25 mg) + Mebendazole (250 mg). After just 6 months: 84.4% had clinical benefit 48.4% had tumor reduction or no detectable disease 86.9% completed treatment with only mild side effects Patients got scans every 3 months. Dr. McCullough breaks it down: tiny doses, massive results, and almost no downside. This is what the cancer industry and Big Pharma fear most — cheap, repurposed drugs actually working while they push trillion-dollar chemo and endless “treatments.” Cancer isn’t being cured because it’s too profitable.

Dr. Dawn Michael

110,104 Aufrufe • vor 2 Tagen

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 4 months, 95.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY. Follow Dr. Zakaria MD. (Dr. Zakaria MD ).
1:12

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 4 months, 95.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY. Follow Dr. Zakaria MD. (Dr. Zakaria MD ).

Joe Tippens

30,145 Aufrufe • vor 3 Monaten

Oncologist: "I've Never Seen Cancers Behaving Like This" Young people, in their 20s, 30s, and 40s, are developing aggressive and rapidly-growing "turbo cancers." "The youngest case that I've reported was a twelve-year-old boy who had one Moderna vaccine. Four months later, [he] developed stage 4 brain cancer. And then six months later, he died," reported MakisMD. "I've diagnosed probably 20,000 cancer patients in my career. I've never seen cancers behaving like this."
0:44

Oncologist: "I've Never Seen Cancers Behaving Like This" Young people, in their 20s, 30s, and 40s, are developing aggressive and rapidly-growing "turbo cancers." "The youngest case that I've reported was a twelve-year-old boy who had one Moderna vaccine. Four months later, [he] developed stage 4 brain cancer. And then six months later, he died," reported MakisMD. "I've diagnosed probably 20,000 cancer patients in my career. I've never seen cancers behaving like this."

The Vigilant Fox 🦊

3,652,846 Aufrufe • vor 2 Jahren

Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. But the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin has multiple anti-cancer effects. “There are at least nine perfectly defined cancer targets affected by ivermectin,” oncologist Dr. Alfonso Dueñas-González, told The Epoch Times. The news outlet reported: "It [ivermectin] has a broad impact on the immune system, increasing immune offense against cancers." "It also inhibits cancer cell cycles, helping prevent the formation of new cancer cells. The drug promotes the killing of cancer cells by inducing mitochondrial stress and prevents cancer survival by preventing new blood vessels, which transport energy and fuel to cancers, from forming near cancer cells." Dr. Kathleen Ruddy, a cancer surgeon, observed a resounding improvement in three patients under her consultation after they started using ivermectin with additional therapies. One patient, facing terminal stage 4 prostate cancer and given only three weeks to live after all treatments failed, began using ivermectin. Remarkably, within two months, his indicators of prostate cancer plummeted, and by six months, his cancer had significantly receded. Less than a year later, he was energetically dancing for four hours, three nights a week. This miraculous recovery was not isolated, as two more patients experienced similar outcomes. Dr. Ruddy, with over 30 years in cancer surgery, reflected on these cases, saying, “I’ve been a cancer surgeon for over 30 years. I’ve never seen anything like this in one patient—let alone three in a row.” Read the full report in the comment below:
3:07

Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. But the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin has multiple anti-cancer effects. “There are at least nine perfectly defined cancer targets affected by ivermectin,” oncologist Dr. Alfonso Dueñas-González, told The Epoch Times. The news outlet reported: "It [ivermectin] has a broad impact on the immune system, increasing immune offense against cancers." "It also inhibits cancer cell cycles, helping prevent the formation of new cancer cells. The drug promotes the killing of cancer cells by inducing mitochondrial stress and prevents cancer survival by preventing new blood vessels, which transport energy and fuel to cancers, from forming near cancer cells." Dr. Kathleen Ruddy, a cancer surgeon, observed a resounding improvement in three patients under her consultation after they started using ivermectin with additional therapies. One patient, facing terminal stage 4 prostate cancer and given only three weeks to live after all treatments failed, began using ivermectin. Remarkably, within two months, his indicators of prostate cancer plummeted, and by six months, his cancer had significantly receded. Less than a year later, he was energetically dancing for four hours, three nights a week. This miraculous recovery was not isolated, as two more patients experienced similar outcomes. Dr. Ruddy, with over 30 years in cancer surgery, reflected on these cases, saying, “I’ve been a cancer surgeon for over 30 years. I’ve never seen anything like this in one patient—let alone three in a row.” Read the full report in the comment below:

The Vigilant Fox 🦊

1,192,158 Aufrufe • vor 2 Jahren

Aspirin might be a surprisingly powerful cancer fighter. New studies re-analyzed old clinical trials and found that taking a low daily dose for several years reduced the overall risk of dying from cancer by about 15%, with especially strong protection against colon, breast, and uterine cancers. The benefit grew over time, and side effects were relatively few. It’s not a miracle cure, but the evidence is compelling enough that doctors are now seriously debating whether low-dose aspirin should become part of routine cancer prevention. Would you start taking daily low-dose aspirin for potential cancer protection, or do you think the idea is still too uncertain?
2:37

Aspirin might be a surprisingly powerful cancer fighter. New studies re-analyzed old clinical trials and found that taking a low daily dose for several years reduced the overall risk of dying from cancer by about 15%, with especially strong protection against colon, breast, and uterine cancers. The benefit grew over time, and side effects were relatively few. It’s not a miracle cure, but the evidence is compelling enough that doctors are now seriously debating whether low-dose aspirin should become part of routine cancer prevention. Would you start taking daily low-dose aspirin for potential cancer protection, or do you think the idea is still too uncertain?

Camus

19,907 Aufrufe • vor 2 Monaten

BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published! (4 min 52 seconds) InfoWars did a media piece on this breakthrough in Cancer Treatment. These are Critical medicines to have on hand. They ship from outside the USSA by our Freedom Crew. They cannot be stopped by lunatic big pharma control freaks. FREEDOM MEDICINE for the WIN "You can use high dose Ivermectin for the majority of Cancers...this is a dose that is 5 to 10 times the dose that people were using for COVID-19". Big Pharma stands to make No Big Money in treating aggressive cancers with High Dose Ivermectin, Fenbendazole, and Turmeric (curcumin). For example, Fenbendazole upregulates p53 tumor suppressor levels, that are low in people who took COVID-19 injections and developed Turbo Cancer. Please Share! #Fenbendazole #ivermectin #Menbendazole #Cancercure
4:52

BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published! (4 min 52 seconds) InfoWars did a media piece on this breakthrough in Cancer Treatment. These are Critical medicines to have on hand. They ship from outside the USSA by our Freedom Crew. They cannot be stopped by lunatic big pharma control freaks. FREEDOM MEDICINE for the WIN "You can use high dose Ivermectin for the majority of Cancers...this is a dose that is 5 to 10 times the dose that people were using for COVID-19". Big Pharma stands to make No Big Money in treating aggressive cancers with High Dose Ivermectin, Fenbendazole, and Turmeric (curcumin). For example, Fenbendazole upregulates p53 tumor suppressor levels, that are low in people who took COVID-19 injections and developed Turbo Cancer. Please Share! #Fenbendazole #ivermectin #Menbendazole #Cancercure

Joe Tippens

100,561 Aufrufe • vor 7 Monaten

Shocking results, hope restored for cancer patients. Cancer vanished in 100% of the patients, after 6 months trial with a drug, dostarlimab, with no significant side effects, first time in history of cancer. Colorectal/rectal cancer the 5th commonest cancer in Africa, and usually by the time its diagnosed it would have spread throughout the body giving low survival rates with the traditional treatment.
3:23

Shocking results, hope restored for cancer patients. Cancer vanished in 100% of the patients, after 6 months trial with a drug, dostarlimab, with no significant side effects, first time in history of cancer. Colorectal/rectal cancer the 5th commonest cancer in Africa, and usually by the time its diagnosed it would have spread throughout the body giving low survival rates with the traditional treatment.

Dr. Misheck Ruwende

107,349 Aufrufe • vor 3 Jahren

Insufficient magnesium intake undermines critical DNA repair enzymes, accelerating DNA damage and raising long-term cancer risk Research shows every 100 mg decrease in daily magnesium intake raises pancreatic cancer risk by 24%, and people with the highest magnesium levels have a 50% lower cancer-related mortality Alarmingly, ~50% of adults in the US consume less than the recommended 320 mg/day (women) or 420 mg/day (men), with athletes needing 10–20% more due to sweating If supplementing, opt for highly bioavailable magnesium salts like malate, citrate, and glycinate
2:46

Insufficient magnesium intake undermines critical DNA repair enzymes, accelerating DNA damage and raising long-term cancer risk Research shows every 100 mg decrease in daily magnesium intake raises pancreatic cancer risk by 24%, and people with the highest magnesium levels have a 50% lower cancer-related mortality Alarmingly, ~50% of adults in the US consume less than the recommended 320 mg/day (women) or 420 mg/day (men), with athletes needing 10–20% more due to sweating If supplementing, opt for highly bioavailable magnesium salts like malate, citrate, and glycinate

FoundMyFitness Clips

62,921 Aufrufe • vor 9 Monaten

100% Cancer Remission Achieved in ALL Patients in Groundbreaking Study Dr. Andrea Cercek, one of the lead researchers, said: “It’s absolutely incredible ... We’ve certainly never seen this before.” All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody. This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies. The authors wrote: “All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging ... and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.” How does this monoclonal antibody actually work? Dr. Cercek explained that it essentially unlocks the body’s ability to heal itself.
3:28

100% Cancer Remission Achieved in ALL Patients in Groundbreaking Study Dr. Andrea Cercek, one of the lead researchers, said: “It’s absolutely incredible ... We’ve certainly never seen this before.” All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody. This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies. The authors wrote: “All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging ... and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.” How does this monoclonal antibody actually work? Dr. Cercek explained that it essentially unlocks the body’s ability to heal itself.

The Vigilant Fox 🦊

1,600,183 Aufrufe • vor 2 Jahren

Dr. Deb Schrag discusses the controversy regarding a study of a new approach to treating rectal cancer that sidesteps the need for radiation, thereby avoiding long-term side effects and preserving fertility. Listen to the full episode:
1:12

Dr. Deb Schrag discusses the controversy regarding a study of a new approach to treating rectal cancer that sidesteps the need for radiation, thereby avoiding long-term side effects and preserving fertility. Listen to the full episode:

NEJM

70,586 Aufrufe • vor 3 Jahren

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 6 months, 84.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY.
1:12

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 6 months, 84.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY.

Nicolas Hulscher, MPH

100,406 Aufrufe • vor 3 Monaten

100% Cancer Remission Achieved in ALL Patients of Groundbreaking Study Dr. Andrea Cercek, one of the lead researchers, said: “It’s absolutely incredible ... We’ve certainly never seen this before.” All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody. This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies. The authors wrote: “All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging ... and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.” How does this monoclonal antibody actually work? Dr. Andrea Cercek explained that it essentially unlocks the body’s ability to heal itself.
3:28

100% Cancer Remission Achieved in ALL Patients of Groundbreaking Study Dr. Andrea Cercek, one of the lead researchers, said: “It’s absolutely incredible ... We’ve certainly never seen this before.” All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody. This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies. The authors wrote: “All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging ... and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.” How does this monoclonal antibody actually work? Dr. Andrea Cercek explained that it essentially unlocks the body’s ability to heal itself.

The Vigilant Fox 🦊

2,527,485 Aufrufe • vor 2 Jahren